The usefulness of hCG and unconjugated oestriol in prenatal diagnosis of trisomy 18

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 103, Issue 4, 1996, Pages 335-338

  Leporrier, N ^a   Herrou, M ^a   Herlicoviez, M ^a   Leymarie, P ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRIOL;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FETUS; GENETIC SCREENING; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; RISK ASSESSMENT; TRISOMY 18; ULTRASOUND;

ADULT; CHORIONIC GONADOTROPIN; CHROMOSOMES, HUMAN, PAIR 18; ESTRIOL; FEMALE; HUMANS; MIDDLE AGED; PREGNANCY; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TRISOMY;

EID: 0029885002     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1996.tb09738.x     Document Type: Article

References (25)

1. Bogart MH, Pandian MR, Jones OW. Abnormal maternal serum chorionic gonadotrophin levels in pregnancies with fetal chromosome abnormalities. Prenat Diagn 1987; 7: 623-630.
2. Crossley JA, Aitken DA, Connor JM. Prenatal screening for chromosome abnormalities using maternal serum chorionic gonadotrophin, alphafetoprotein and age. Prenat Diagn 1991; 11: 83-101.
3. Norgaard-Pedersen B, Larsen SO, Arends J, Svenstrup B, Tabor A. Maternal serum markers in screening for Down syndrome. Clin Genet 1990; 37: 35-43.
4. Crossley JA, Aitken DA, Connor JM. Second-trimester un-conjugated oestriol levels in maternal serum from chromosomally abnormal pregnancies using an optimized assay. Prenat Diagn 1993: 13: 271-280.
5. Merkatz IR, Nitowsky HM, Macri JN, Johnston WE. An association between low maternal serum alphafetoprotein and fetal chromosome abnormalities. Am J Obster Gynecol 1984; 148: 886-894.
6. Lindenbaum RH, Ryynanen M, Holmes-Siedle M, Puhakainen E, Jonasson J, Keenan J. Trisomy 18 and maternal serum and amniotic fluid alphafetoprotein. Prenat Diagn 1987; 7: 511-519.
7. Canick JA, Palomaki GE, Osathanondh R. Prenatal screening for trisomy 18 in the second trimester. Prenat Diagn 1990; 10: 546-548.
8. Staples AJ, Robertson EF, Ranieri E, Ryall RG, Haan EA. A maternal serum screen for trisomy 18: An extension of maternal serum screening for Down syndrome. Am J Hum Genet 1991; 49: 1025-1033.
9. Palomaki GE, Knight GJ, Haddow JE, Canick JA, Saller DN, Panizza DS. Prospective intervention trial of a screening protocol to identify fetal trisomy 18 using maternal serum alphafetoprotein, unconjugated oestriol, and human chorionic gonadotropin. Prenat Diagn 1992; 12: 925-930.
10. Spencer K, Mallard AS, Coombes EJ, Macri JN. Prenatal screening for trisomy 18 with free p human chorionic gonadotrophin as a marker. BMJ 1993; 307: 1455-1458.
11. Herrou M, Leporrier N, Leymarie P. Screening for fetal Down syndrome with maternal serum hCG and oestriol: A prospective study. Prenat Diagn 1992; 12: 887-892.
12. Leporrier N, Herrou M, Leymarie P. Antenatal screening for Down’s syndrome. BMJ 1992; 305: 1017-1018.
13. Cuckle HS, Wald NJ. Screening for Down’s syndrome. In: Lilford R, editor. Prenatal diagnosis and prognosis. London : Butterworth, 1990: 67-91.
14. Greenberg F, Schmidt D, Darnule AT, Weyland BR, Rose E, Alpert E. Maternal serum α-fetoprotein, β-human chorionic gonadotropin, and unconjugated estriol levels in midtrimester trisomy 18 pregnancies. Am J Obstet Gynecol 1992; 166: 1388-1392.
15. Barkai G, Goldman L, Ries L, Chaki R, Zer T, Cuckle H. Expanding multiple marker screening for Down’s syndrome to include Edward’s syndrome. Prenat Diagn 1993; 13: 843-850.
16. Saller DN, Canick JA, Palomaki GE, Knight GJ, Haddow JE. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects. Obstet Gynecol 1994; 84: 852-855.
17. Davies T. Prenatal screening for trisomy 18 should not be contemplated. BMJ 1994; 308: 471.
18. Hook EB. Chromosome abnormalities and spontaneous fetal death following amniocentesis: further data and associations with maternal age. Am J Hum Genet 1983; 35: 110-116.
19. Eydoux P, Choiset A, Leporrier N et al. Chromosomal prenatal diagnosis: study of 936 cases of intrauterine abnormalities after ultrasound assessment. Prenat Diagn 1989; 9: 255-268.
20. Halliday J, Lumley J, Bankier A. Karyotype abnormalities in fetuses diagnosed as abnormal on ultrasound before 20 weeks’ gestational age. Prenat Diagn 1994; 14: 689-697.
21. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ 1992; 304: 867-869.
22. Achiron R, Rotstein Z, Lipitz S, Mashiach S, Hegesh J. First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 1994; 84: 69-72.
23. Romero R, Pilu G, Jeanty P, Ghidini A, Hobbins JC. Congenital contractures: Clubfoot. Rocker-bottom foot. In Prenatal Diagnosis of Congenital Anomalies. Norwalk, CT : Appleton and Lange, 1988: 377-380.
24. Walkinshaw S, Pilling D, Spriggs A. Isolated choroid plexus cysts. The need for routine offer of karyotyping. Prenat Diagn 1994; 14: 663-667.
25. Nora JJ, Nora AH. Genetics and Counselling in Cardiovascular Disease. Springfield, IL : Chas C Thomas, 1978.